NCT07558057

Cognitive Impairment in Patients Undergoing Cell- and Antibody-based Immunotherapies for Haematological Malignancies: The COGNITOX Study

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-03-31Est. Completion: 2032-03-31

Enrollment target: 225 participants

Locations

Lymphoplasmacytic LymphomaWaldenstrom Macroglobulinemia

This phase II trial studies the effects of venetoclax and rituximab in comparison to ibrutinib and rituximab or zanubrut…

Tucson, United StatesEst. completion Mar 31, 2028

Waldenstrom MacroglobulinemiaLymphoplasmacytic LymphomaMonoclonal B-Cell LymphocytosisSmall Lymphocytic LymphomaCLL (Chronic Lymphocytic Leukemia)

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.